PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Phone208-939-8900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$266.69 million
Profitability
Miscellaneous
Employees225
OptionableOptionable
PetIQ (NASDAQ:PETQ) Frequently Asked Questions
What is PetIQ's stock symbol?
PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
How were PetIQ's earnings last quarter?
PetIQ Inc (NASDAQ:PETQ) issued its quarterly earnings results on Tuesday, August, 14th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.02. The business had revenue of $171.10 million for the quarter, compared to the consensus estimate of $148.48 million. PetIQ had a positive return on equity of 11.68% and a negative net margin of 0.12%. PetIQ's revenue was up 96.2% on a year-over-year basis. View PetIQ's Earnings History.
When is PetIQ's next earnings date?
What price target have analysts set for PETQ?
5 brokers have issued 12-month target prices for PetIQ's stock. Their forecasts range from $39.00 to $50.00. On average, they anticipate PetIQ's stock price to reach $44.00 in the next twelve months. This suggests a possible upside of 48.7% from the stock's current price. View Analyst Price Targets for PetIQ.
What is the consensus analysts' recommendation for PetIQ?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.
What are Wall Street analysts saying about PetIQ stock?
Here are some recent quotes from research analysts about PetIQ stock:
- 1. Jefferies Financial Group Inc analysts commented, "PETQ remains our top small-cap growth idea post our mgmt meetings / co.’s bullish presentation at the ICR conf. in Orlando, FL. Mgmt underscored secular tailwinds in the attractive pet health industry remain very much in place, the co." (1/15/2019)
- 2. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (6/6/2018)
Has PetIQ been receiving favorable news coverage?
News headlines about PETQ stock have been trending somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PetIQ earned a coverage optimism score of 0.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are some of PetIQ's key competitors?
Who are PetIQ's key executives?
PetIQ's management team includes the folowing people:
- Mr. McCord Christensen, Chairman & CEO (Age 47)
- Mr. John Newland, CFO & Corp. Sec. (Age 55)
- Ms. Susan Sholtis, Pres (Age 53)
When did PetIQ IPO?
(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
Who are PetIQ's major shareholders?
PetIQ's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.77%), State of New Jersey Common Pension Fund D (3.83%), D. E. Shaw & Co. Inc. (2.28%), Pembroke Management LTD (2.25%), Peregrine Capital Management LLC (2.19%) and Massachusetts Financial Services Co. MA (1.61%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Ronald Kennedy and Will Santana. View Institutional Ownership Trends for PetIQ.
Which major investors are selling PetIQ stock?
PETQ stock was sold by a variety of institutional investors in the last quarter, including Summit Partners Public Asset Management LLC, Millennium Management LLC, Timpani Capital Management LLC, Bank of New York Mellon Corp, Essex Investment Management Co. LLC, Raymond James & Associates, Castleark Management LLC and Advisor Group Inc.. Company insiders that have sold PetIQ company stock in the last year include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen and Will Santana. View Insider Buying and Selling for PetIQ.
Which major investors are buying PetIQ stock?
PETQ stock was bought by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., BlackRock Inc., D. E. Shaw & Co. Inc., Gabelli Funds LLC, Massachusetts Financial Services Co. MA, State of New Jersey Common Pension Fund D, Dimensional Fund Advisors LP and Geode Capital Management LLC. View Insider Buying and Selling for PetIQ.
How do I buy shares of PetIQ?
Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PetIQ's stock price today?
One share of PETQ stock can currently be purchased for approximately $29.59.
How big of a company is PetIQ?
PetIQ has a market capitalization of $833.40 million and generates $266.69 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. PetIQ employs 225 workers across the globe.
What is PetIQ's official website?
How can I contact PetIQ?
PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]
MarketBeat Community Rating for PetIQ (NASDAQ PETQ)
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
